Tralee, Ireland

Time filter

Source Type

Grant
Agency: Cordis | Branch: FP7 | Program: CP-TP | Phase: KBBE.2011.1.2-06 | Award Amount: 3.99M | Year: 2012

The proposed project aims to develop innovative methods, tools and concepts for the replacement of copper in European organic and low input fruit, grapevine, potato, and tomato production systems. Copper-free production systems will be achieved by (i) providing alternative compounds, (ii) smart application tools and (iii) by integrating these tools into traditional and novel copper-free crop production systems. The copper-free apple, grapevine, potato and tomato production systems will be (iv) evaluated in a multi-criteria assessment with respect to agronomic, ecologic and economic performance. CO-FREE will also develop strategies to develop (v) smart breeding goals by development of crop ideotypes and (vi) foster consumer acceptance of novel disease-resistant cultivars by consumers and retailers. By involving farmers, advisors, plant protection industry, policy makers and researchers as well as the stakeholders of the European organic and low input sector (food supply chain, retailers, producers associations), CO-FREE will ensure a rapid development, dissemination and adoption of the copper replacement strategies. The multidisciplinary consortium proposed for the project includes 11 academic and 9 industry (all SMEs) partners from 10 European countries. All partner institutions are leaders in their respective fields and/or are leading providers of advisory services to farmers, retailers, policy makers and other stakeholders in the organic and low input sector.


Grant
Agency: Cordis | Branch: FP7 | Program: CP-TP | Phase: KBBE.2012.1.2-03 | Award Amount: 7.69M | Year: 2012

BIOFECTOR is an integrated project that develops alternative fertilisation strategies by the use of various bio-effectors (BEs, plant growth promoting microorganisms and natural extraction products). BEs stimulate root growth, solubilise and mineralise sparingly available nutrients, or protect plants from abiotic and biotic stresses. Novel BEs will be isolated, characterized and applied in strategic combination with alternative fertilisation strategies that include organic and low-input farming, use of waste recycling fertilizers, and fertiliser-placement technologies. Bio-effectors addressed comprise fungal strains of Trichoderma, Penicillium and Sebacinales, as well as bacterial strains of Bacillus and Pseudomonades with well-characterized root growth promoting and nutrient solubilising potential. Natural extraction products of seaweed, compost and plant extracts, as well as their purified active compounds are also tested in various combinations. Maize, wheat and tomato are chosen as representative crops. Laboratory and European-wide field experiments assure product adaptation to divers geo-climatic conditions. Viable alternatives to the conventional practice of mineral fertilisation are developed, towards environmental friendly agricultural practice with reduced agrochemical input.


News Article | December 2, 2016
Site: www.newsmaker.com.au

Demand for biostimulants is expected to surpass US$ 4 billion in revenues, according to a new research report by Future Market Insights (FMI). The report titled, “Biostimulants Market: Global Industry Analysis and Opportunity Assessment 2015-2025” forecasts the demand for biostimulants to expand at a CAGR of nearly 11% through 2025. Biostimulants are finding increasing application in the agriculture sector owing to their environmentally-friendly and organic nature. Rising food demand is putting pressure on land and focus has shifted to enhancing the yield per hectare. “Governments around the world are speeding up efforts to boost agricultural production. Use of biostimulants is being encouraged to improve the overall output, and this is expected to fuel demand in the near future”, said the FMI analyst who compiled the report. Although FMI expects the demand for biostimulants to expand at a robust pace during the forecast period 2015-2025, certain factors can impede growth. “Lack of standardisation and slow pace of innovation are the key restraining factors for the global biostimulants market.” Biostimulants are used in foliar, seed, and soil; among these, use of biostimulants is highest in the foliar segment, accounting for nearly one-third market share in 2014. On the basis of crop type, use of biostimulants is predominant in row crops, and fruits and vegetables. Application of biostimulants in turf and ornamental is at a nascent stage currently. FMI forecasts the turf and ornamental segment to expand at a CAGR of over 6% during 2015-2025. Demand for acid-based biostimulants is higher than acid-based- and extract-based biostimulants, owing to easy availability of raw materials and higher efficiency. Biostimulants containing Vitamin B, chitin and chitosan are expected to gain traction during the forecast period. Western Europe is the largest market for biostimulants, accounting for over 30% market value share in 2014. Focus on enhancing yield per hectare coupled with government support are the key factors propelling the growth of the market in the region. Asia Pacific Excluding Japan is emerging as a lucrative market for biostimulants. The agriculture sector in the region is witnessing a shift from traditional farming practices to use of technology and additives, owing to which biostimulants are expected to gain traction in the next decade. Acadian Seaplants Limited, Biostadt India Limited, Omex Agrifluids Ltd., Italpollina Spa, Koppert B.V., BioAtlantis Ltd., Micromix Plant Health Limited, Trade Corporation International, Valagro S.p.A, Isagro S.p.A, Platform Specialty Products Corporation,  BASF SE, Novozymes A/S, Agrinos A/S and The Dow Chemical Company.


News Article | November 18, 2016
Site: www.newsmaker.com.au

Demand for biostimulants is expected to surpass US$ 4 billion in revenues, according to a new research report by Future Market Insights (FMI). The report titled, “Biostimulants Market: Global Industry Analysis and Opportunity Assessment 2015-2025” forecasts the demand for biostimulants to expand at a CAGR of nearly 11% through 2025. Biostimulants are finding increasing application in the agriculture sector owing to their environmentally-friendly and organic nature. Rising food demand is putting pressure on land and focus has shifted to enhancing the yield per hectare. “Governments around the world are speeding up efforts to boost agricultural production. Use of biostimulants is being encouraged to improve the overall output, and this is expected to fuel demand in the near future”, said the FMI analyst who compiled the report. Although FMI expects the demand for biostimulants to expand at a robust pace during the forecast period 2015-2025, certain factors can impede growth. “Lack of standardisation and slow pace of innovation are the key restraining factors for the global biostimulants market.” Biostimulants are used in foliar, seed, and soil; among these, use of biostimulants is highest in the foliar segment, accounting for nearly one-third market share in 2014. On the basis of crop type, use of biostimulants is predominant in row crops, and fruits and vegetables. Application of biostimulants in turf and ornamental is at a nascent stage currently. FMI forecasts the turf and ornamental segment to expand at a CAGR of over 6% during 2015-2025. Demand for acid-based biostimulants is higher than acid-based- and extract-based biostimulants, owing to easy availability of raw materials and higher efficiency. Biostimulants containing Vitamin B, chitin and chitosan are expected to gain traction during the forecast period. Western Europe is the largest market for biostimulants, accounting for over 30% market value share in 2014. Focus on enhancing yield per hectare coupled with government support are the key factors propelling the growth of the market in the region. Asia Pacific Excluding Japan is emerging as a lucrative market for biostimulants. The agriculture sector in the region is witnessing a shift from traditional farming practices to use of technology and additives, owing to which biostimulants are expected to gain traction in the next decade. Acadian Seaplants Limited, Biostadt India Limited, Omex Agrifluids Ltd., Italpollina Spa, Koppert B.V., BioAtlantis Ltd., Micromix Plant Health Limited, Trade Corporation International, Valagro S.p.A, Isagro S.p.A, Platform Specialty Products Corporation,  BASF SE, Novozymes A/S, Agrinos A/S and The Dow Chemical Company.


Grant
Agency: Cordis | Branch: H2020 | Program: MSCA-ITN-EID | Phase: MSCA-ITN-2014-EID | Award Amount: 1.27M | Year: 2015

The project provides advanced systems biology training for 5 ESRs who will develop novel methods for increasing crop strength and resistance to stress by alternative genetic and genomic, non-GMO, technologies: (1) Selecting allelic variants of a novel gene identified by members of the consortium which regulates oxidative and abiotic stress tolerance and (2) Molecular priming by biostimulants or low doses of H2O2 to induce stress-protective mechanisms in crops. This dual approach will meet the growing EU push towards secure, sustainable and safe means of food production (Dir.2009/128/EC & EU Reg. EC/178/2002). The genetic approaches are combined with high-throughput technologies for transcriptome, metabolome, and phenotypic analyses, combined with advanced bioinformatics. Both approaches to increasing crop yield are growing in importance, with the biostimulants industry expected to reach $2.2B globally by 2018. Equipping ESRs with these skills will enable them to develop their research careers in academia or industry. Training will be conducted at the University of Potsdam (UP, Coordinator), Germany, and two companies: BioAtlantis (BA), Ireland, and Enza Zaden (EZ), The Netherlands. Prof. B. Mueller-Roeber (UP) has extensive research management and teaching experience and will supervise the ESRs as PhD students. BA is internationally recognized for producing innovative biostimulants and has 3 patents filed, while EZ is among the top ten in vegetable breeding worldwide. All partners have experience in coordination and participation in EU FP7 projects. The expected results will increase our understanding of the molecular basis of stress tolerance and provide two alternative strategies for crop improvement and increasing food production. BA and EZ will ensure rapid dissemination of applied research to end users.


Grant
Agency: Cordis | Branch: FP7 | Program: BSG-SME | Phase: SME-2012-1 | Award Amount: 1.69M | Year: 2012

Pig and poultry farming are amongst the most important agricultural activities in the EU, and significant performance gains were previously achieved through the use of in-feed antibiotics. The THRIVE-RITE project aims to provide a strong competitive advantage in these sectors by maximising the performance using natural feed additives as alternatives to the use of in-feed growth promoting antibiotics, which were recently banned in agriculture. Therefore, as antibiotic growth-promoting effects are no longer available to the industry, there is an urgent need to find innovative and long term solutions to maximising the growth performance and efficiency within the pig and poultry sectors to ensure the benefits of safe, wholesome and a sustainable supply of quality food products to the end user can be achieved. The THRIVE-RITE project will address these issues by undertaking a comprehensive programme of nutrition research to inform the industry of the benefits of functional foods derived from natural sources as additives to animal feed. Natural feed additives produced by a consortia of SMEs will be assessed by research partners to determine (1) their impact on infectious agents that cause major production losses in the pig and poultry industries, (2) to enhance the safety of meat products by reducing the presence of three of the major bacterial infections associated with human food-borne illness (Salmonella, Campylobacter and E. coli species) and (3) antioxidant value to pig and poultry meat for improving its quality and shelf life. The project will be of benefit to and impact on primary livestock producers, animal health and welfare, SMEs and provide a higher quality product to the end consumer. THRIVE-RITE provides a clear potential for alternatives to in-feed antibiotics and the program is designed to ensure that the information is disseminated to provide effective tools and long-term solutions to the industry for livestock health and production management.


This invention relates to the improvement of gastrointestinal health, immunity and performance by direct dietary intervention with a composition comprising a glucan and/or a fucan, and relates in particular to the transfer of associated health benefits to offspring via glucan and/or a fucan supplementation of the maternal diet. Accordingly the present invention provides a composition comprising at least one glucan, at least one fucan, or at least one glucan and at least one fucan for use in improving or maintaining the gastrointestinal health or function of a progeny of a maternal animal by administration to the maternal animal, and a method for improving or maintaining the gastrointestinal health or function of a progeny of a maternal animal, the method comprising administering a composition comprising at least one glucan, at least one fucan, or at least one glucan and at least one fucan to the maternal animal.


Patent
BioAtlantis | Date: 2014-03-20

A non-nematicidal composition comprises at least one glucan and/or at least one fucan which act individually or synergistically with mannitol to reduce losses in crop yield and marketable grade caused by the infestation of growth media with plant pathogenic nematodes, to levels equivalent to those achieved with commercial nematicides, but without posing a risk to the ecosystem or user. In some cases the composition comprises at least one glucan, at least one fucan and at least one mannitol which may be in a weight/weight ratio of approximately 1:2:3 of at least one glucan:at least one fucan:at least one mannitol or between approximately 1:1:1 to 1:1:3 of at least one glucan:at least one fucan:at least one mannitol.


This invention relates to the improvement of gastrointestinal health, immunity and performance by direct dietary intervention with a composition comprising a glucan and/or a fucan, and relates in particular to the transfer of associated health benefits to offspring via glucan and/or a fucan supplementation of the maternal diet. Accordingly the present invention provides a composition comprising at least one glucan, at least one fucan, or at least one glucan and at least one fucan for use in improving or maintaining the gastrointestinal health or function of a progeny of a maternal animal by administration to the maternal animal; and a method for improving or maintaining the gastrointestinal health or function of a progeny of a maternal animal, the method comprising administering a composition comprising at least one glucan, at least one fucan, or at least one glucan and at least one fucan to the maternal animal.


News Article | May 30, 2014
Site: www.finsmes.com

Today, we publish an interview with Ger Goold, a Partner withIrish venture capital firm Kernel Capital. He a has a finance background and joined Kernel in 2009. Ger focuses on Early Stage and Series A investments and recently led investments in Altratech and Tapastreet. Directorships include MPSTOR and BioAtlantis. Prior to joining Kernel Capital, he worked in the energy sector in Queensland for a period, particularly focused on M&A transactions, and previous to that he spent 6 years with KPMG where he managed services to both Nasdaq-quoted multinationals and Irish tech startups. FinSMEs: What’s Kernel Capital? What’s the investment strategy? Ger: Kernel Capital is a venture capital firm with offices in Cork, Dublin and Belfast, managing the Bank of Ireland Kernel Capital Venture Funds which are one of the largest and most active sources of equity finance for technology companies on the island of Ireland. Our strategic alliance with Bank of Ireland and our network of over 80 institutional portfolio co-investors ensures Kernel Capital delivers an ‘access to funding’ continuum for all stages of company growth. To date, our team of six fulltime Partners have raised €173m in venture capital funds, the latest being in 2013; have led over 100 investments; and have assisted our portfolio companies to raise over €500m in equity and debt funding. The Bank of Ireland Kernel Capital Venture Funds are independently managed by Kernel Capital. We leverage our extensive network to enable our portfolio companies recruit the highest calibre people, to break into new international markets and to generate revenues of scale. Our portfolio companies employ over 1,100 people on the island of Ireland, almost all at graduate and post graduate level. Our investment focus and expertise is on Information & Communications Technology and Engineering. Within these sectors we invest primarily in patent and ‘know how’ driven knowledge based companies, where the company promoters can demonstrate to us their vision and ability to create compelling new products and services. Our primary focus is on leading institutional Series A investments in the range of €1.5m to €5m. FInSMEs: Personally, what do you like to see in startup founders? What don’t you like to see in them? Ger: We aim to partner with resilient people of exceptional vision and ability from first time founders to seasoned entrepreneurs – pioneers who innovate and create new products and services. We like a demonstrable ability to access a sufficiently large market, or at least an understanding of the challenges to be overcome. We don’t expect founders to have all the answers, but it is important to have an appreciation of the questions. And no matter how technical the team is it needs to listen to the market and be focused on why their product will be bought. FinSMEs: Today, a new wave of thematic funds is raising. In your opinion, can it result in a real advantage for the industry and for backed companies? Ger: As the European VC market matures greater specialisation is to be expected as domain expertise deepens and new funds aim to differentiate their market offering. We are therefore likely to see more thematic niche funds launching, however the underlying market needs to be of a sufficient scale to support such funds e.g. you reference station12, which is targeting a $250m raise focused on European Media tech. At Kernel Capital we invest across the island of Ireland with a focus on ICT and Engineering, where we have deep sectoral expertise and a successful track record which allows us to bring clear value-add to our investees. Importantly this is a market where we see excellent deal-flow opportunities and where we are clearly differentiated as a market leader; this works for us. Specialised thematic funds is a strategy for new funds to segment the market, not a new concept. The VC market is no different to any other market, each participant decides on how to tailor their offering to the market in the context of their particular skillsets, something we have always done at Kernel Capital to some considerable success. FinSMEs: Speak about some trends…fintech, IoT, wearable tech, virtual reality, etc. Which one do you bet on? Ger: We get most excited by great teams with great products addressing large markets which they can credibly access. What those specific markets are is of less significance, and quite often by the time a particular market is trending the value investments have passed. Saying that, we are currently in the process of closing an investment in a company targeting an emerging market in the fintech space; the broad IoT space is an area we have been investing in with years, with a particular focus on upstream processes such as investees FeedHenry, enabling enterprise-mobility, and MPSTOR, who are providing disruptive software to the data-centre; while an existing investee Lumafit are in the middle of a very successful Kickstarter campaign for the launch of its fantastic wearable tech product. So all of the above and none of the above!

Loading BioAtlantis collaborators
Loading BioAtlantis collaborators